Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436)

J. R. Infante; G. S. Falchook; D. P. Lawrence; J. S. Weber; R. F. Kefford; J. C. Bendell; R. Kurzrock; G. Shapiro; R. R. Kudchadkar; G. V. Long; H. A. Burris; K. B. Kim; A. Clements; S. Peng; B. Yi; A. J. Allred; D. Ouellet; K. Patel; P. F. Lebowitz; K. T. Flaherty

doi:10.1200/jco.2011.29.18_suppl.cra8503

Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436)

J. R. Infante, G. S. Falchook, D. P. Lawrence, J. S. Weber, R. F. Kefford, J. C. Bendell, R. Kurzrock, G. Shapiro, R. R. Kudchadkar, G. V. Long, H. A. Burris, K. B. Kim, A. Clements, S. Peng, B. Yi, A. J. Allred, D. Ouellet, K. Patel, P. F. Lebowitz, K. T. Flaherty

Faculty of Medicine, Health and Human Sciences

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	CRA8503
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	29
Issue number	18
DOIs	https://doi.org/10.1200/jco.2011.29.18_suppl.cra8503
Publication status	Published - 20 Jun 2011

Access to Document

10.1200/jco.2011.29.18_suppl.cra8503

Cite this

Infante, J. R., Falchook, G. S., Lawrence, D. P., Weber, J. S., Kefford, R. F., Bendell, J. C., Kurzrock, R., Shapiro, G., Kudchadkar, R. R., Long, G. V., Burris, H. A., Kim, K. B., Clements, A., Peng, S., Yi, B., Allred, A. J., Ouellet, D., Patel, K., Lebowitz, P. F., & Flaherty, K. T. (2011). Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436). Journal of Clinical Oncology, 29(18), CRA8503. https://doi.org/10.1200/jco.2011.29.18_suppl.cra8503

@article{0798a726c34e415ca6e069bf4df79873,

title = "Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436)",

author = "Infante, {J. R.} and Falchook, {G. S.} and Lawrence, {D. P.} and Weber, {J. S.} and Kefford, {R. F.} and Bendell, {J. C.} and R. Kurzrock and G. Shapiro and Kudchadkar, {R. R.} and Long, {G. V.} and Burris, {H. A.} and Kim, {K. B.} and A. Clements and S. Peng and B. Yi and Allred, {A. J.} and D. Ouellet and K. Patel and Lebowitz, {P. F.} and Flaherty, {K. T.}",

year = "2011",

month = jun,

day = "20",

doi = "10.1200/jco.2011.29.18_suppl.cra8503",

language = "English",

volume = "29",

pages = "CRA8503",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "18",

}

Infante, JR, Falchook, GS, Lawrence, DP, Weber, JS, Kefford, RF, Bendell, JC, Kurzrock, R, Shapiro, G, Kudchadkar, RR, Long, GV, Burris, HA, Kim, KB, Clements, A, Peng, S, Yi, B, Allred, AJ, Ouellet, D, Patel, K, Lebowitz, PF & Flaherty, KT 2011, 'Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436)', Journal of Clinical Oncology, vol. 29, no. 18, pp. CRA8503. https://doi.org/10.1200/jco.2011.29.18_suppl.cra8503

Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436). / Infante, J. R.; Falchook, G. S.; Lawrence, D. P. et al.
In: Journal of Clinical Oncology, Vol. 29, No. 18, 20.06.2011, p. CRA8503.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436)

AU - Infante, J. R.

AU - Falchook, G. S.

AU - Lawrence, D. P.

AU - Weber, J. S.

AU - Kefford, R. F.

AU - Bendell, J. C.

AU - Kurzrock, R.

AU - Shapiro, G.

AU - Kudchadkar, R. R.

AU - Long, G. V.

AU - Burris, H. A.

AU - Kim, K. B.

AU - Clements, A.

AU - Peng, S.

AU - Yi, B.

AU - Allred, A. J.

AU - Ouellet, D.

AU - Patel, K.

AU - Lebowitz, P. F.

AU - Flaherty, K. T.

PY - 2011/6/20

Y1 - 2011/6/20

U2 - 10.1200/jco.2011.29.18_suppl.cra8503

DO - 10.1200/jco.2011.29.18_suppl.cra8503

M3 - Meeting abstract

SN - 0732-183X

VL - 29

SP - CRA8503

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 18

ER -